Meyka Pro banner
UiPath Inc.

Stay Updated with the Latest UiPath Inc. PATH News in Real Time

Find PATH news now at Meyka AI. Stay informed with the latest UiPath Inc. stocks updates, including price news, market analysis, and expert insights.

PATHNYSE
TechnologySoftware - Infrastructure
$16.23
$0.46(2.88%)
U.S. Market is Open · 15:45
European Stocks Post Worst Week Since July: Stoxx 600 Drops 1.14% as Oil Surge and Bond Yields Bite
📅 3 hours ago

European Stocks Post Worst Week Since July: Stoxx 600 Drops 1.14% as Oil Surge and Bond Yields Bite

European Stocks closed a rough week on August 21, 2026, with the Stoxx 600 down 1.14%, its steepest five-day slide since July 6. Rising Brent crude prices and surging bond yields drove the sell-off. Germany’s 10-year Bund yield hit 3.22%, its highest level since 2011, while Brent crude touched $93.56 a barrel on Thursday.  Tech…

Read more 12
Bitcoin Price Today: BTC Soars 8% to $74,982 as Crypto Rally Explodes; Ethereum, XRP Surge
📅 6 hours ago

Bitcoin Price Today: BTC Soars 8% to $74,982 as Crypto Rally Explodes; Ethereum, XRP Surge

Bitcoin surged 8% to $74,982 on Friday, August 21, 2026, extending a powerful weekly rally. The cryptocurrency has now climbed nearly 20% since Monday, fueled by a surprise US Treasury policy shift. Ethereum jumped toward $2,300, gaining roughly 18% in 24 hours, while XRP surged past $1.25.  Total crypto market capitalization reached $2.56 trillion, up…

Read more 12
Gold Price Today: MCX Gold Jumps to ₹1,60,250. Why Gold Is Rising as Dollar Weakens, Fed Bets Shift
📅 7 hours ago

Gold Price Today: MCX Gold Jumps to ₹1,60,250. Why Gold Is Rising as Dollar Weakens, Fed Bets Shift

MCX gold price rose 0.52% to ₹1,60,250 on August 21, 2026, supported by a weaker dollar and falling US yields. September silver futures declined 1.02% to ₹2,45,736 on the same session. Healthy spot market demand and positive global cues drove bullion higher today. Brent crude slipped 0.27% to $93.52 a barrel, adding further support to…

Read more 12
Tech Stocks to Watch: Alphabet Lifts 2026 Capex Forecast to $195B-205B
📅 8 hours ago

Tech Stocks to Watch: Alphabet Lifts 2026 Capex Forecast to $195B-205B

Alphabet is spending more to keep up with demand for artificial intelligence. On July 22, 2026, the Google parent raised its 2026 capital expenditure forecast to $195 billion-$205 billion, up from $180 billion-$190 billion. The increase comes as Google Cloud revenue jumped 82% to $24.8 billion in the second quarter. As AI demand drives higher…

Read more 12
Hanson Pushes 75% Tobacco Tax Cut to Undercut Black Market on August 21
📅 9 hours ago

Hanson Pushes 75% Tobacco Tax Cut to Undercut Black Market on August 21

Pauline Hanson proposes cutting Australia’s tobacco excise by 75% to reduce illegal cigarette sales. A packet would fall from A$46.50 to roughly A$21-22 if retailers pass savings on.

Read more 12
Moderna Tumbles 23.5% After 177% Surge on Cancer Vaccine Win, August 21
📅 16 hours ago

Moderna Tumbles 23.5% After 177% Surge on Cancer Vaccine Win, August 21

Moderna stock fell 23.5% to $133.32 on August 21 after surging 177% the prior day on its cancer vaccine breakthrough with Merck. RSI hit record 92.21, signaling extreme overbought conditions.

Read more 12
Hyperliquid USD Surges 5% to $73.20 on Trump Regulatory Signal
📅 18 hours ago

Hyperliquid USD Surges 5% to $73.20 on Trump Regulatory Signal

HYPEUSD rallied 5% to $73.20 after President Trump signaled regulatory engagement for U.S. compliance on August 19, with CFTC meeting today.

Read more 12
Jake Stringer Exits GWS Giants, Plans Return to Melbourne for Family in 2027
📅 20 hours ago

Jake Stringer Exits GWS Giants, Plans Return to Melbourne for Family in 2027

Jake Stringer confirms he will leave GWS Giants after this weekend’s game against Adelaide, planning to return to Melbourne in 2027 for family reasons. The 32-year-old will play his 250th AFL game on Saturday.

Read more 12
Moderna Soars 177% on Melanoma Vaccine Win; Merck Gains 12% on August 20
📅 1 day ago

Moderna Soars 177% on Melanoma Vaccine Win; Merck Gains 12% on August 20

Moderna jumps 177% and Merck rises 12% after their mRNA cancer vaccine meets Phase 3 endpoints for melanoma. The combo reduced cancer recurrence and spread in over 1,100 patients.

Read more 12

PATH News FAQ